Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 236.58 USD -0.46%
Market Cap: 170.9B USD
Have any thoughts about
Danaher Corp?
Write Note

Danaher Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Danaher Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Danaher Corp
NYSE:DHR
Operating Income
$4.5B
CAGR 3-Years
-14%
CAGR 5-Years
9%
CAGR 10-Years
3%
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.4B
CAGR 3-Years
-12%
CAGR 5-Years
12%
CAGR 10-Years
15%
West Pharmaceutical Services Inc
NYSE:WST
Operating Income
$585.8m
CAGR 3-Years
-5%
CAGR 5-Years
15%
CAGR 10-Years
13%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.6B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
37%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.2B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
14%
No Stocks Found

Danaher Corp
Glance View

Market Cap
170.9B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Danaher Corporation, a dynamic and innovative global science and technology company, has established itself as a leader in the life sciences, diagnostics, water quality, and applied solutions sectors. Founded in 1969, Danaher has consistently pursued a strategy of acquiring and nurturing businesses that align with its core focus on advancing health and enhancing the quality of life. By leveraging its strong operational framework known as the Danaher Business System (DBS), the company excels in driving efficiency and innovation across its diverse portfolio. With a commitment to R&D, Danaher continually develops cutting-edge technologies that address critical challenges faced by healthcare, environmental monitoring, and industrial applications. From its beginnings, Danaher has built a reputation for strong organic growth and robust financial performance. Investors are drawn to its disciplined approach to acquisitions, which not only enhances revenue streams but also integrates companies that provide synergistic benefits. With a solid financial foundation characterized by impressive margins and consistently high return on investment, Danaher appears well-positioned for long-term growth. As global demand for health and environmental solutions continues to rise, Danaher’s strategic investments and innovative capabilities make it a compelling choice for investors seeking exposure to the essential sectors of life sciences and diagnostics.

DHR Intrinsic Value
191.95 USD
Overvaluation 19%
Intrinsic Value
Price

See Also

What is Danaher Corp's Operating Income?
Operating Income
4.5B USD

Based on the financial report for Sep 27, 2024, Danaher Corp's Operating Income amounts to 4.5B USD.

What is Danaher Corp's Operating Income growth rate?
Operating Income CAGR 10Y
3%

Over the last year, the Operating Income growth was -19%. The average annual Operating Income growth rates for Danaher Corp have been -14% over the past three years , 9% over the past five years , and 3% over the past ten years .

Back to Top